{"disease":{"id":"heterotopic-ossification","name":"Heterotopic ossification","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":3,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"etidronic-acid","indication_name":"Heterotopic ossification","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Didronel","generic_name":"ETIDRONIC ACID","company_name":"Procter And Gamble","drug_phase":"marketed","molecular_target":"","drug_class":"Bisphosphonate","quality_score":30,"revenue":null,"mechanism":""},{"drug_id":"ethidronate","indication_name":"Heterotopic ossification","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Ethidronate","company_name":"Centre National d'Etudes Spatiales","drug_phase":"phase_1","molecular_target":"Type IV secretion-like conjugative transfer relaxase protein TraI","drug_class":"","quality_score":7,"revenue":null,"mechanism":""},{"drug_id":"etidronate","indication_name":"Heterotopic ossification","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Etidronate","company_name":"Organon and Co","drug_phase":"phase_3","molecular_target":"Type IV secretion-like conjugative transfer relaxase protein TraI","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":3,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06903299","title":"Prospective Investigation of Intra-Articular Tranexamic Acid Use in Elective Hip Arthroplasty","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"St. Anne's University Hospital Brno, Czech Republic","has_results":false},{"nct_id":"NCT06251349","title":"Comparative Analysis of Radiotherapeutic and Medical Procedures for the Prophylaxis of Heterotopic Ossifications","phase":"","overall_status":"COMPLETED","enrollment_count":512,"lead_sponsor_name":"University of Jena","has_results":false},{"nct_id":"NCT03974698","title":"Uncemented Hemiarthroplasty, Radiological Features Comparing Lateral Versus Anterolateral Approach","phase":"NA","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"Sorlandet Hospital HF","has_results":false},{"nct_id":"NCT04867278","title":"Heterotopic Ossification Prophylaxis","phase":"NA","overall_status":"COMPLETED","enrollment_count":117,"lead_sponsor_name":"University of Maryland, Baltimore","has_results":true},{"nct_id":"NCT03925688","title":"Assessment of Heterotopic Ossification of Elbow Joint in Relation of Serum Uric Acid.","phase":"","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT05218954","title":"Balance in Patients With Ectopic Bone Tissue After Total Hip Replacement","phase":"","overall_status":"COMPLETED","enrollment_count":88,"lead_sponsor_name":"Medical University of Warsaw","has_results":false},{"nct_id":"NCT06088407","title":"Tranexamic Acid Prophylaxis for Heterotopic Ossification in Elbow Fracture-Dislocation Surgery","phase":"NA","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Assaf-Harofeh Medical Center","has_results":false},{"nct_id":"NCT03724422","title":"HO Prophylaxis Therapy for Distal Humerus Fractures","phase":"NA","overall_status":"TERMINATED","enrollment_count":3,"lead_sponsor_name":"University of Louisville","has_results":true},{"nct_id":"NCT04577820","title":"Study to Assess the Efficacy and Safety of Garetosmab in Japanese Adult Patients With Fibrodysplasia Ossificans Progressiva (FOP)","phase":"PHASE3","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Regeneron Pharmaceuticals","has_results":false},{"nct_id":"NCT04867018","title":"Defining the Pathophysiology of Heterotopic Ossification: A Prospective Study","phase":"","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Vanderbilt University Medical Center","has_results":false}],"total":10},"guidelines":[],"source":"Drug Landscape verified database"}